• USP42 Drives Breast Cancer by Blocking JNK/p38-Mediated Apop

  2026-05-25

  The referenced study identifies USP42 as a key promoter of breast cancer progression, acting via inhibition of the JNK/p38 apoptotic signaling pathway. By integrating molecular, cellular, and in vivo analyses, the research reveals USP42 as a potential therapeutic target for overcoming apoptosis resistance in breast cancer.

• Rosiglitazone (Brl-49653): PPARγ Agonist for Type II Diabete

  2026-05-25

  Rosiglitazone, also known as Brl-49653, is a synthetic thiazolidinedione PPARγ agonist with well-documented utility in type II diabetes research. This agent enhances insulin sensitivity and adipogenesis by modulating PPARγ-driven gene expression, with effects confirmed in both cellular and animal models. Its applications extend to mechanistic dissection of adipocyte biology and the rescue of partial PPARγ loss-of-function mutations.

• Force-Threshold Regulation of Root Resorption via Nrf2/Keap1

  2026-05-24

  This study uncovers how varying magnitudes of orthodontic force modulate root resorption through the Nrf2/Keap1/p62 antioxidant pathway. By defining the force-dependent activation and saturation thresholds of Nrf2, the research identifies a mechanosensitive switch linking oxidative stress, inflammation, and tissue remodeling with implications for therapeutic prevention of root resorption.

• Hematoxylin and Eosin Staining Kit: Technical Guide and QC

  2026-05-23

  The Hematoxylin and Eosin Staining Kit (SKU: K1142) addresses the need for reliable, ready-to-use solutions for tissue morphology visualization in research settings. It is best suited for histopathological and cytological studies using paraffin or frozen tissue sections, but is not intended for diagnostic or medical applications. This guide provides actionable workflow and troubleshooting advice for laboratory scientists.

• BMS-777607: Transforming MET Pathway Research & Platelet Pro

  2026-05-22

  Explore how BMS-777607, a highly selective c-Met inhibitor from APExBIO, is redefining translational research by bridging advanced cancer models and stem cell-derived platelet protocols. This article delivers mechanistic insight, actionable protocol guidance, and strategic vision for researchers leveraging MET signaling pathway inhibition to unlock new frontiers in metastasis suppression and functional platelet generation.

• Balsalazide Disodium: Novel 5-ASA Prodrug in Ulcerative Coli

  2026-05-22

  Wiggins and Rajapakse’s reference study details the unique design and clinical performance of balsalazide disodium—a prodrug engineered to optimize 5-aminosalicylic acid (5-ASA) delivery for ulcerative colitis. Their findings underscore its superior induction of remission and favorable tolerability profile, highlighting its translational relevance for both clinical and preclinical inflammation research.

• HyperScribe All in One mRNA Synthesis Kit: Precision & Evide

  2026-05-21

  The HyperScribe All in One mRNA Synthesis Kit Plus 1 enables the rapid, reproducible synthesis of ARCA-capped, polyadenylated mRNA with immune-evasive modifications. This ARCA capped mRNA synthesis kit supports advanced applications such as RNA vaccine development and in vitro translation of modified mRNA, with performance validated by recent preclinical studies. Robust yield, translational efficiency, and immune response reduction are its core strengths.

• Proximity Mapping of RAB GTPases via Enzyme-Mediated Labelin

  2026-05-21

  This study presents a comprehensive proximity proteome map for 23 human RAB GTPases using APEX2-catalyzed labeling. The resulting dataset illuminates the transient and context-dependent interactions governing membrane trafficking, providing a new reference for dissecting RAB-regulated pathways in cellular biology.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S

  2026-05-20

  This study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids and stromal cell subpopulations to more accurately represent tumor microenvironment complexity. The approach reveals how stromal cells modulate drug response and gene expression, providing an advanced platform for personalized drug screening and resistance mechanism studies.

• Oleanolic Acid: Inducible Nitric Oxide Synthase Induction in

  2026-05-20

  Oleanolic acid stands out as a DMSO-soluble triterpenoid enabling robust inducible nitric oxide synthase induction and cyclooxygenase-2 modulation, crucial for advanced liposome-based antiviral and immune pathway research. This guide delivers optimized workflows, troubleshooting intelligence, and practical insights for dual-loaded nanoliposome encapsulation, leveraging APExBIO's high-purity standard and the latest nanoparticle exclusion chromatography advances.

• ROS-Degradable Lipid Nanoparticles for Tumor-Selective mRNA

  2026-05-19

  This study introduces a combinatorial library of biodegradable lipid nanoparticles, engineered with ROS-degradable thioketal moieties, to achieve tumor-selective mRNA delivery and mutant RAS pathway inhibition. The findings highlight a potent, cell-selective strategy for mRNA therapeutics, providing mechanistic and translational insights for cancer research.

• Surfactant-Derived LNPs Advance mRNA Delivery to Macrophages

  2026-05-19

  This study introduces a dual-component lipid nanoparticle (LNP) system utilizing surfactant-derived ionizable lipids for efficient intracellular mRNA delivery to macrophages. The findings offer a promising non-viral strategy for genetic engineering of hard-to-transfect immune cells, with potential implications for mRNA therapeutics and gene regulation studies.

• KU-60019 (SKU A8336): Enhancing ATM Kinase Inhibition in Can

  2026-05-18

  This article provides a scenario-driven, evidence-based exploration of KU-60019 (SKU A8336), a potent and selective ATM kinase inhibitor for advanced cell-based assays. Readers will find practical guidance for assay design, protocol optimization, data interpretation, and vendor selection, with direct links to validated resources and performance data for KU-60019.

• Morning Endurance Training Promotes Superior Muscle Adaptati

  2026-05-18

  Hesketh et al. demonstrate that endurance training during the early active (morning) phase produces greater improvements in performance and skeletal muscle adaptation in mice than identical training in the afternoon. This work highlights the importance of exercise timing for optimizing metabolic and physiological research outcomes.

• G007-LK Tankyrase 1/2 Inhibitor: Precision Control of Wnt an

  2026-05-17

  Explore the dual impact of G007-LK, a potent tankyrase 1/2 inhibitor, on Wnt/β-catenin and Hippo signaling in APC-mutant colorectal cancer and hepatocellular carcinoma research. This article delivers advanced insights and practical assay guidance not found in existing resources.

16347 records 1/1090 page Next 12345 下5页 Last page